Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia

Genotype-phenotype correlation

Judith Mallolas, M. Antònia Vilaseca, Jaume Campistol, Nilo Lambruschini, Francisco José Cambra, Xavier P. Estivill, Montserrat Milà

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Hyperphenylalaninemia (HPA) is a group of diseases characterized by the persistent elevation of phenylalanine levels in tissues and biological fluids. It is an autosomal recessive disorder affecting 1 in 10,000 individuals in Caucasian populations and about 1 in 6600 in Catalonia. We report the mutational spectrum of phenylalanine hydroxylase deficiency in the population living in Catalonia and the genotype-phenotype correlation. The molecular study was performed in 383 samples corresponding to 115 patients from 99 unrelated families and 268 relatives. We have characterized 90% of the mutant alleles; there were 57 different mutations, 49 of which have previously been described, 8 being novel mutations and two being large deletions. The 57 mutations detected corresponded to: five nonsense, seven frameshift, and eight splice defects, the remainder being missense mutations. These mutations cause 72 different genotypes in the 83 families characterized, confirming the mutational heterogeneity of phenylketonuria (PKU) in the Mediterranean population. According to our biochemical classification, our HPA population is composed of 40 PKU (35%), 36 variant PKU (31%), and 39 non-PKU HPA (34%). Mutations such as IVS10, A403 V,and E390G correlated as expected with the phenotype and the predicted residual activity in vitro. However, in four cases (I65 T, V388 M, R261Q, and Y414 C), the observed metabolic phenotype was not consistent with the predicted genotypic effect. The identification of the mutations in the PAH gene and the genotype-phenotype correlation should facilitate the evaluation of metabolic phenotypes, diagnosis, implementation of optimal dietary therapy, and determination of prognosis in the patients and genetic counselling for the patient's relatives.

Original languageEnglish
Pages (from-to)468-473
Number of pages6
JournalHuman Genetics
Volume105
Issue number5
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Phenylketonurias
Genetic Association Studies
Mutation
Population
Phenotype
Genetic Counseling
Missense Mutation
Phenylalanine
Alleles
Genotype
Genes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia : Genotype-phenotype correlation. / Mallolas, Judith; Vilaseca, M. Antònia; Campistol, Jaume; Lambruschini, Nilo; Cambra, Francisco José; Estivill, Xavier P.; Milà, Montserrat.

In: Human Genetics, Vol. 105, No. 5, 1999, p. 468-473.

Research output: Contribution to journalArticle

Mallolas, Judith ; Vilaseca, M. Antònia ; Campistol, Jaume ; Lambruschini, Nilo ; Cambra, Francisco José ; Estivill, Xavier P. ; Milà, Montserrat. / Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia : Genotype-phenotype correlation. In: Human Genetics. 1999 ; Vol. 105, No. 5. pp. 468-473.
@article{e9707a9b75464439ba79b8b50dedafcd,
title = "Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia: Genotype-phenotype correlation",
abstract = "Hyperphenylalaninemia (HPA) is a group of diseases characterized by the persistent elevation of phenylalanine levels in tissues and biological fluids. It is an autosomal recessive disorder affecting 1 in 10,000 individuals in Caucasian populations and about 1 in 6600 in Catalonia. We report the mutational spectrum of phenylalanine hydroxylase deficiency in the population living in Catalonia and the genotype-phenotype correlation. The molecular study was performed in 383 samples corresponding to 115 patients from 99 unrelated families and 268 relatives. We have characterized 90{\%} of the mutant alleles; there were 57 different mutations, 49 of which have previously been described, 8 being novel mutations and two being large deletions. The 57 mutations detected corresponded to: five nonsense, seven frameshift, and eight splice defects, the remainder being missense mutations. These mutations cause 72 different genotypes in the 83 families characterized, confirming the mutational heterogeneity of phenylketonuria (PKU) in the Mediterranean population. According to our biochemical classification, our HPA population is composed of 40 PKU (35{\%}), 36 variant PKU (31{\%}), and 39 non-PKU HPA (34{\%}). Mutations such as IVS10, A403 V,and E390G correlated as expected with the phenotype and the predicted residual activity in vitro. However, in four cases (I65 T, V388 M, R261Q, and Y414 C), the observed metabolic phenotype was not consistent with the predicted genotypic effect. The identification of the mutations in the PAH gene and the genotype-phenotype correlation should facilitate the evaluation of metabolic phenotypes, diagnosis, implementation of optimal dietary therapy, and determination of prognosis in the patients and genetic counselling for the patient's relatives.",
author = "Judith Mallolas and Vilaseca, {M. Ant{\`o}nia} and Jaume Campistol and Nilo Lambruschini and Cambra, {Francisco Jos{\'e}} and Estivill, {Xavier P.} and Montserrat Mil{\`a}",
year = "1999",
doi = "10.1007/s004390051132",
language = "English",
volume = "105",
pages = "468--473",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia

T2 - Genotype-phenotype correlation

AU - Mallolas, Judith

AU - Vilaseca, M. Antònia

AU - Campistol, Jaume

AU - Lambruschini, Nilo

AU - Cambra, Francisco José

AU - Estivill, Xavier P.

AU - Milà, Montserrat

PY - 1999

Y1 - 1999

N2 - Hyperphenylalaninemia (HPA) is a group of diseases characterized by the persistent elevation of phenylalanine levels in tissues and biological fluids. It is an autosomal recessive disorder affecting 1 in 10,000 individuals in Caucasian populations and about 1 in 6600 in Catalonia. We report the mutational spectrum of phenylalanine hydroxylase deficiency in the population living in Catalonia and the genotype-phenotype correlation. The molecular study was performed in 383 samples corresponding to 115 patients from 99 unrelated families and 268 relatives. We have characterized 90% of the mutant alleles; there were 57 different mutations, 49 of which have previously been described, 8 being novel mutations and two being large deletions. The 57 mutations detected corresponded to: five nonsense, seven frameshift, and eight splice defects, the remainder being missense mutations. These mutations cause 72 different genotypes in the 83 families characterized, confirming the mutational heterogeneity of phenylketonuria (PKU) in the Mediterranean population. According to our biochemical classification, our HPA population is composed of 40 PKU (35%), 36 variant PKU (31%), and 39 non-PKU HPA (34%). Mutations such as IVS10, A403 V,and E390G correlated as expected with the phenotype and the predicted residual activity in vitro. However, in four cases (I65 T, V388 M, R261Q, and Y414 C), the observed metabolic phenotype was not consistent with the predicted genotypic effect. The identification of the mutations in the PAH gene and the genotype-phenotype correlation should facilitate the evaluation of metabolic phenotypes, diagnosis, implementation of optimal dietary therapy, and determination of prognosis in the patients and genetic counselling for the patient's relatives.

AB - Hyperphenylalaninemia (HPA) is a group of diseases characterized by the persistent elevation of phenylalanine levels in tissues and biological fluids. It is an autosomal recessive disorder affecting 1 in 10,000 individuals in Caucasian populations and about 1 in 6600 in Catalonia. We report the mutational spectrum of phenylalanine hydroxylase deficiency in the population living in Catalonia and the genotype-phenotype correlation. The molecular study was performed in 383 samples corresponding to 115 patients from 99 unrelated families and 268 relatives. We have characterized 90% of the mutant alleles; there were 57 different mutations, 49 of which have previously been described, 8 being novel mutations and two being large deletions. The 57 mutations detected corresponded to: five nonsense, seven frameshift, and eight splice defects, the remainder being missense mutations. These mutations cause 72 different genotypes in the 83 families characterized, confirming the mutational heterogeneity of phenylketonuria (PKU) in the Mediterranean population. According to our biochemical classification, our HPA population is composed of 40 PKU (35%), 36 variant PKU (31%), and 39 non-PKU HPA (34%). Mutations such as IVS10, A403 V,and E390G correlated as expected with the phenotype and the predicted residual activity in vitro. However, in four cases (I65 T, V388 M, R261Q, and Y414 C), the observed metabolic phenotype was not consistent with the predicted genotypic effect. The identification of the mutations in the PAH gene and the genotype-phenotype correlation should facilitate the evaluation of metabolic phenotypes, diagnosis, implementation of optimal dietary therapy, and determination of prognosis in the patients and genetic counselling for the patient's relatives.

UR - http://www.scopus.com/inward/record.url?scp=0032756656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032756656&partnerID=8YFLogxK

U2 - 10.1007/s004390051132

DO - 10.1007/s004390051132

M3 - Article

VL - 105

SP - 468

EP - 473

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 5

ER -